Piramal Pharma Share Price
212.45-2.04 (-0.95%)
+5.61% past 1 Year
News
Piramal Pharma raises stake in Yapan Bio, makes it a subsidiary
Equity
PPLPHARMA
Piramal Pharma, Carlyle selldown cancellation reported by IIFL
Equity
PPLPHARMA
Piramal Pharma sees Rs 29.81 crores NSE block trade at Rs 205.01
Equity
PPLPHARMA
Piramal Pharma Restarts Ahmedabad Operations After Flood Disruption
Equity
PPLPHARMA
Goldman Sachs reiterates Buy on Piramal Pharma with Rs 250 target
Equity
PPLPHARMA
Piramal Pharma maintains steady capex guidance with Lexington project on schedule
Equity
PPLPHARMA
Piramal Pharma highlights elevated effective tax rate during current fiscal scale-up
Equity
PPLPHARMA
Piramal Pharma reiterates full-year guidance for complex hospital generics
Equity
PPLPHARMA
Piramal Pharma maintains existing guidance, potential update after September quarter
Equity
PPLPHARMA
Piramal Pharma management reiterates full-year CDMO revenue guidance on concall
Equity
PPLPHARMA
Piramal Pharma reiterates FY30 target of 25 percent EBITDA margin
Equity
PPLPHARMA
Piramal Pharma maintains FY27 capex guidance at Rs 12-13.5 crores
Equity
PPLPHARMA
Piramal Pharma guides for EBITDA margin expansion on overseas growth visibility
Equity
PPLPHARMA
Piramal Pharma guides elevated FY27 tax rate before gradual normalization
Equity
PPLPHARMA
Piramal Pharma may revise FY27 performance guidance in upcoming Q2 concall
Equity
PPLPHARMA
Piramal Pharma posts higher Q1 EBITDA and margin on annual basis
Equity
PPLPHARMA
Piramal Pharma reports strong Q1 revenue growth on year-on-year basis
Equity
PPLPHARMA
Piramal Pharma reports narrower consolidated net loss in Q1 FY2026 results
Equity
PPLPHARMA
Piramal Pharma sees Rs 18.10 crores NSE block trade in shares
Equity
PPLPHARMA
PPLPHARMA sees Rs 76.21 crore BSE block trade at Rs 191 per share
Equity
PPLPHARMA